(Q46715156)

24 December 2017

title

Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene (English)

1 reference

24 December 2017

author

Frank G. Schaap

3

1 reference

24 December 2017

author name string

C Priore Oliva

1

1 reference

24 December 2017

F Carubbi

2

1 reference

24 December 2017

S Bertolini

4

1 reference

24 December 2017

S Calandra

5

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

24 December 2017

Journal of Internal Medicine

published in

1 reference

24 December 2017

volume

263

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

450-458

1 reference

24 December 2017

Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Familial combined hyperlipidemia: upstream transcription factor 1 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Identification of lipid binding and lipoprotein lipase activation domains of human apoAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01912.X

10.1111/J.1365-2796.2007.01912.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017